Navigation Links
Logical Therapeutics Announces Positive Results of LT-NS001 vs. Naproxen Clinical Study
Date:10/27/2009

-NS001 with our next study scheduled to begin later this year."

Key Findings Presented at ACG

In this study, 120 normal volunteers aged 45 to 70 years received either LT-NS001 (n=61) or Naprosyn(®) (naproxen) (n=59) for seven days and underwent an upper GI endoscopy at baseline and on day seven to visualize the extent of GI injury. At the conclusion of the study, nine subjects (15.8%) had developed gastric ulcers while taking naproxen, compared with only two subjects (3.3%) on LT-NS001, a 78 percent reduction in the incidence of gastric ulcers (p=0.02). The total number of ulcers that developed in the naproxen arm was twenty-nine (29) compared to only three (3) in the LT-NS001 arm, leading to a significant difference in the mean number of gastric ulcers per subject (p=0.03). Additionally, subjects receiving LT-NS001 developed no duodenal ulcers. The primary endpoint for the trial, total modified gastroduodenal Lanza score (an indicator of GI injury) demonstrated less overall GI mucosal injury in the LT-NS001 subjects as compared to subjects receiving naproxen (p=0.03). Treatment emergent adverse events also favored LT-NS001 with no serious or severe adverse events, including fewer incidences of abdominal pain, gastritis and dyspepsia.

"The results of this initial study demonstrate a potential new approach to the treatment of patients who suffer from chronic painful diseases such as osteoarthritis with the use of an NSAID having the possibility of a lower incidence of GI side effects traditionally associated with naproxen," said Thomas J. Schnitzer, MD, PhD, Professor of Medicine, Internal Medicine/Rheumatology at Northwestern University Feinberg School of Medicine. "LT-NS001 has the potential to be a very valuable option for patients and health care providers if further studies with LT-NS001 demonstrate a reduced risk for NSAID-induced GI complications, a side effect which often results in discontinuation of arthriti
'/>"/>

SOURCE Logical Therapeutics, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. S*BIO to Develop New JAK-2 Inhibitor for Treatment of Myeloproliferative Disorders and Hematological Malignancies
2. Biological Psychiatry Publishes Study Showing VYVANSE Demonstrated Significant Efficacy for Treatment of ADHD for up to 12 Hours After Administration
3. European Commission Approves ATRIPLA(R) (efavirenz 600 mg/emtricitabine 200 mg/tenofovir disoproxil fumarate 300 mg), the First Once-Daily Single Tablet Regimen for Virologically Suppressed Adults With HIV-1 Infection
4. Neurobiological Technologies, Inc. and Buck Institute Partner to Develop Novel Treatment for Alzheimers Disease
5. Nventa Announces Positive Interim Immunological Data From HspE7 Phase 1 Cervical Dysplasia Trial
6. Fifth DSMB Meeting Supports Neurobiological Technologies Continuation of Phase 3 Stroke Trials With Viprinex(TM) (ancrod)
7. Nventa Announces Additional Positive Immunological Data From HspE7 Phase 1 Cervical Dysplasia Trial
8. Neurobiological Technologies, Inc. Presents Dosing Rationale for Viprinex(TM) (ancrod) at the European Stroke Conference
9. Indevus Presents Successful Phase III NEBIDO(R) Data at American Urological Association
10. Cryoablation Is Focus of 17 Clinical Studies at American Urological Association Annual Meeting
11. TARGETED GENE DELIVERY IN VIVO: Rexin-G Monotherapy Reveals Significant Biological Activity Without Toxicity in Chemo-Resistant Metastatic Breast Cancer (ASCO 2008)
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/19/2014)... , Sept. 19, 2014  For Cloud ... drug design and development, partnering is an integral ... is to design new drugs and identify early ... partners to further their development. The company also ... To support this business model, Cloud Pharmaceuticals will ...
(Date:9/19/2014)... Sept. 19, 2014  Diplomat, the nation,s largest independent ... Dreyer to the Board of Directors on September ... will also serve as chair of the Audit Committee. ... of accounting, financial, compliance and operating experience in the ... served as chief financial officer, chief operating officer and ...
(Date:9/19/2014)... -- Alere Inc. (NYSE: ALR ), a global ... in support of President Barack Obama,s Executive ... leader in rapid diagnostics for infectious disease, we commend ... the serious threat of antibiotic resistance. We look forward ... to promote the development of rapid point-of-care tests that, ...
Breaking Medicine Technology:Cloud Pharmaceuticals Announces Partnering Sessions and Presentation Schedule 2David Dreyer Appointed to Diplomat Board of Directors 2Alere Applauds President's Executive Order Combating Antibiotic-Resistant Bacteria 2
... 19, 2011 MMIS , Inc. ... compliance solutions for the life science industry, announced the ... aggregate spend reporting solution, at the ExL Pharma 2nd ... MediSpend™ allows pharmaceutical, medical device and biotechnologies companies to ...
... Health today announced a joint venture with leading China ... to doctors in China as the country prepares for ... Wolters Kluwer Health to expand its market-leading Clinical Decision ... growing China market and creates a needed drug information ...
Cached Medicine Technology:MMIS, Inc. Launches the MediSpend™ Aggregate Spend Solution 2Wolters Kluwer Health Enters Joint Venture with China Drug Information Provider Medicom 2Wolters Kluwer Health Enters Joint Venture with China Drug Information Provider Medicom 3
(Date:9/19/2014)... 19, 2014 Singulair, developed by Merck, ... of leukotriene D4 (LTD4). LTD4 belongs to the family ... of cells, including mast cells and eosinophils, and which ... have determined that there are higher concentrations of Cys-LTs ... non-asthmatic individuals. The production of CysLTs is increased in ...
(Date:9/19/2014)... University researchers say a simple test that combines ... risk for developing Alzheimer,s disease in a person, ... of dementia., Faculty of Health Professor Lauren Sergio ... study asked the participants to complete four increasingly ... laptop computers. The test aimed at detecting the ...
(Date:9/19/2014)... September 19, 2014 The ... traditional Scandinavian style of eating, is making ... like Diet Doc’s medical weight loss ... and eating good food which leads to ... on teaching patients to understand how diet ...
(Date:9/19/2014)... September 19, 2014 2013 NEXT ... named a finalist for the 2014 NEXT Awards ... president Tammy Hawes has been selected as the ... The Nashville Area Chamber of Commerce and the ... to recognize the accomplishments of companies and individual ...
(Date:9/19/2014)... King of Prussia, PA (PRWEB) September 19, 2014 ... provider of Business Process Outsourcing solutions for Health ... and Managed Medicaid markets, will sponsor a Networking ... Director in the Health Industry Advisory Practice at ... 30, 2014 at the AHIP’s 2014 National Conference ...
Breaking Medicine News(10 mins):Health News:Singulair Asthma Market to 2023 – Etiology, Pathophysiology, Diagnosis & Treatment Overview in New Report Available at LifeScienceIndustryResearch.com 2Health News:Singulair Asthma Market to 2023 – Etiology, Pathophysiology, Diagnosis & Treatment Overview in New Report Available at LifeScienceIndustryResearch.com 3Health News:Singulair Asthma Market to 2023 – Etiology, Pathophysiology, Diagnosis & Treatment Overview in New Report Available at LifeScienceIndustryResearch.com 4Health News:Simple test can help detect Alzheimer's before dementia signs show: York U study 2Health News:Diet Doc’s Medical Weight Loss Programs Announce Diet Plans Based on the Same Principles as the New Nordic Diet 2Health News:Diet Doc’s Medical Weight Loss Programs Announce Diet Plans Based on the Same Principles as the New Nordic Diet 3Health News:Diet Doc’s Medical Weight Loss Programs Announce Diet Plans Based on the Same Principles as the New Nordic Diet 4Health News:Virsys12 and Founder Tammy Hawes Each Named 2014 NEXT Awards Finalists 2Health News:Virsys12 and Founder Tammy Hawes Each Named 2014 NEXT Awards Finalists 3Health News:TMG Health To Sponsor Pricewaterhouse Coopers Speaker at AHIP’s National Conference on Medicare 2Health News:TMG Health To Sponsor Pricewaterhouse Coopers Speaker at AHIP’s National Conference on Medicare 3
... /PRNewswire-FirstCall/ Medizone International,Inc. (Pink Sheets: MZEI) announces ... TDV Global, Inc. (TDVGlobal.com). TDV Global,is a ... Approximately 70% of their business involves consulting ... private enterprise,mostly in the Health and Security ...
... 4 Senesco,Technologies, Inc. ("Senesco" or the "Company") ... will be presenting at the 10th Annual,Rodman & ... the New York,Palace Hotel from November 10-12, 2008. ... will deliver the Company,s corporate,presentation on Tuesday, November ...
... WELLINGTON, Fla., Nov. 4 The Quantum Group,Inc. ... healthcare organization,announced today that Noel J. Guillama, President ... Investment,s 31st Annual Westergaard,Conference on November 12, 2008. ... Vice President and Chief Technology & Innovations Officer,and ...
... and Conference Call ... 8%, HAYWARD, Calif., Nov. 4 Thermage, Inc.,(Nasdaq: ... third quarter,ended September 30, 2008 for both Thermage and ... it may update its Form,S-4 filing with the Securities ...
... connects employers and candidates faster, brings unprecedented functionality and ease of ... ... 4, 2008 -- Dayak, the leading online recruiting marketplace ... easier, and more efficiently, today launched a new version of its ...
... for the Achievement,of Human Potential (IAHP) announced today that ... on The Institutes, world,headquarters in Wyndmoor, Pennsylvania on December ... Child" -- an intensive course covering every,aspect of special ... child who is almost normal but not quite., ...
Cached Medicine News:Health News:Medizone International, Inc. Announces Strategic Consulting Relationship With TDV Global, Inc. 2Health News:Senesco Technologies to Present at 10th Annual Rodman & Renshaw Healthcare Conference 2Health News:Senesco Technologies to Present at 10th Annual Rodman & Renshaw Healthcare Conference 3Health News:The Quantum Group Inc. To Present at Paulson Investment's 31st Annual Westergaard Conference 2Health News:The Quantum Group Inc. To Present at Paulson Investment's 31st Annual Westergaard Conference 3Health News:Thermage Discloses Preliminary 3Q 2008 Results for Thermage and Reliant 2Health News:Thermage Discloses Preliminary 3Q 2008 Results for Thermage and Reliant 3Health News:Thermage Discloses Preliminary 3Q 2008 Results for Thermage and Reliant 4Health News:Dayak Makes Hiring Even Easier, Unveils New Version Of Web Interface For Employers 2Health News:Dayak Makes Hiring Even Easier, Unveils New Version Of Web Interface For Employers 3Health News:Parenting Course at The Institutes for the Achievement of Human Potential Gives Parents the Tools to Help their Special Needs Kids Have a Fighting Chance 2
... Volks revolutionary MiniQuad, the DynaView 156 is ... of the retina extending to the ora ... patients. Featuring a minified housing and reduced ... revolutionizes retinopathy of prematurity surgery and is ...
... If you prefer a standard ... the Volk Iridectomy Lens. Its ... view you're used to but ... Volk's exclusive Double Aspheric design ...
... re-designed Super Macula® 2.2 offers extremely high ... fovea, while achieving an exceptionally wide 78° ... excellent choice for critical evaluation of the ... for detailed views of the macula and ...
... The Volk TransEquator is designed for ... diagnosis. Its unique optical design presents a ... an impressive wide-field view of the entire ... superior optics of this lens allows dynamic ...
Medicine Products: